كوليستيبول

High molecular weight resin-polymer similar in action to cholesteramine. It prevents the normal reabsorption of bile acids and forces the liver to produce more bile, thus reducing the body's cholesterol levels (especially LDL), since cholesterol is a major component of bile. Oral administration once or twice a day. 

At the time of the last update, we did not find any published data regarding lactation. 

The intestinal absorption of the drug is null ^{(AEMPS 2016, Pfizer 2013)}, so it cannot pass into breast milk, nor would it pass into the infant's plasma from ingested breast milk. 

Its high molecular weight makes it very unlikely to pass significant amounts into breast milk. It is unlikely to alter the lipid composition of milk. 

Prolonged use may cause plasma deficiency, due to lack of absorption, of fat-soluble vitamins (A, D, E, K), so it may be advisable to supplement to avoid deficiency of these vitamins in breast milk. 

Several experts and expert consensuses consider safe or probably safe the use of this medication during breastfeeding. ^{(Hale, LactMed, Lawrence 2016 p393, Serrano 2015, Briggs 2015)}

It is advisable to follow a lipid-lowering diet and to engage in regular daily physical activity, at least half an hour daily.

For considerations on the appropriateness of lipid-lowering treatment during breastfeeding see Maternal hyperlipidemia, hypercholesterolemia, hypertriglyceridemia.

See below the information of this related product:

• Maternal Hyperlipidemia, Hypercholesterolemia, Hypertriglyceridemia (Safe substance and/or breastfeeding is the best option.)